Pharmacokinetics of FK 506: preclinical and clinical studies.
作者信息
Venkataramanan R, Jain A, Cadoff E, Warty V, Iwasaki K, Nagase K, Krajack A, Imventarza O, Todo S, Fung J J
机构信息
School of Pharmacy, University of Pittsburgh, PA 15261.
出版信息
Transplant Proc. 1990 Feb;22(1):52-6.
Abstract
摘要
相似文献
1
Pharmacokinetics of FK 506: preclinical and clinical studies.
Transplant Proc. 1990 Feb;22(1):52-6.
2
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
3
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
Transplant Proc. 1990 Feb;22(1):57-9.
4
Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.
J Pharmacobiodyn. 1991 Jan;14(1):34-42. doi: 10.1248/bpb1978.14.34.
5
Toxicologic evaluation of FK 506.
Transplant Proc. 1990 Feb;22(1):83-6.
6
The oral dosage form of FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):17-22.
7
Biopharmaceutical aspects of FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):30-5.
8
Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy.
Biol Blood Marrow Transplant. 2006 Dec;12(12):1352-4. doi: 10.1016/j.bbmt.2006.07.009.
9
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
Transplant Proc. 1998 Jun;30(4):1299-302. doi: 10.1016/s0041-1345(98)00250-4.
10
Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction.
J Pharm Pharmacol. 2000 Dec;52(12):1467-72. doi: 10.1211/0022357001777676.
引用本文的文献
1
Safety and Efficacy of Infusional Perioperative Tacrolimus Therapy in Crohn's Disease Patients Undergoing Intestinal Resection.
Inflamm Intest Dis. 2024 Nov 18;10(1):18-33. doi: 10.1159/000542443. eCollection 2025 Jan-Dec.
2
Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling.
Biomedicines. 2024 Aug 22;12(8):1926. doi: 10.3390/biomedicines12081926.
3
Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience.
J Clin Med. 2024 Mar 28;13(7):1968. doi: 10.3390/jcm13071968.
4
Drug-induced CYP induction as therapy for tacrolimus intoxication.
Clin Nephrol Case Stud. 2022 May 23;10:42-46. doi: 10.5414/CNCS110744. eCollection 2022.
5
Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation.
Pharmacy (Basel). 2020 Apr 3;8(2):60. doi: 10.3390/pharmacy8020060.
6
Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
Clin Pharmacol Drug Dev. 2019 Nov;8(8):995-1008. doi: 10.1002/cpdd.657. Epub 2019 Jan 22.
7
Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients.
Front Med (Lausanne). 2018 Nov 19;5:320. doi: 10.3389/fmed.2018.00320. eCollection 2018.
8
The Diabetic Dog as a Translational Model for Human Islet Transplantation.
Yale J Biol Med. 2017 Sep 25;90(3):509-515. eCollection 2017 Sep.
9
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations.
AAPS J. 2017 Sep;19(5):1332-1347. doi: 10.1208/s12248-017-0119-z. Epub 2017 Jul 17.
10
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.
Cell Mol Immunol. 2017 Feb;14(2):146-179. doi: 10.1038/cmi.2016.39. Epub 2016 Oct 10.
本文引用的文献
1
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.
Transplant Proc. 1988 Feb 1;20(1 suppl 1):220-222.
2
Biopharmaceutical aspects of FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):30-5.
3
The oral dosage form of FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):17-22.
Zotero 插件